UCB (UCBJF) recently announced that it has licensed exclusive global rights to tozadenant (SYN115) for Parkinson’s disease from Biotie Therapies.
Tozadenant is an...(read more
Lannett Company, Inc. (LCI) recently announced that the US Food and Drug Administration (FDA) granted approval to the company’s abbreviated new drug application (ANDA) for its generic...(read more
Lannett Co. Inc. (NYSE: LCI) reports Q4 EPS of $0.11, versus the consensus of $0.08. Lannett Co. Inc. reports revenues of $33.8 million, versus the consensus of $32.03 million.
"Strong sales of our pain management drugs in the...(read more